Phio Pharmaceuticals Corp Stock Price on December 12, 2024
| PHIO Stock | USD 2.70 0.14 4.93% |
Below is the normalized historical share price chart for Phio Pharmaceuticals Corp extending back to May 10, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phio Pharmaceuticals stands at 2.70, as last reported on the 18th of December 2024, with the highest price reaching 2.70 and the lowest price hitting 2.70 during the day.
If you're considering investing in Phio Stock, it is important to understand the factors that can impact its price. Phio Pharmaceuticals Corp maintains Sharpe Ratio (i.e., Efficiency) of -0.041, which implies the firm had a -0.041% return per unit of risk over the last 3 months. Phio Pharmaceuticals Corp exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phio Pharmaceuticals' Risk Adjusted Performance of (0.01), variance of 37.5, and Coefficient Of Variation of (4,992) to confirm the risk estimate we provide.
At this time, Phio Pharmaceuticals' Stock Based Compensation To Revenue is very stable compared to the past year. . At this time, Phio Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 18th of December 2024, Price Sales Ratio is likely to grow to 274.78, while Price Earnings Ratio is likely to drop (0.15). Phio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of May 2012 | 200 Day MA 5.1867 | 50 Day MA 3.0725 | Beta 1.465 |
Phio |
Sharpe Ratio = -0.041
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PHIO |
Estimated Market Risk
| 6.02 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Phio Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phio Pharmaceuticals by adding Phio Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6059 | Enterprise Value Ebitda 0.6124 | Price Sales 48.0082 | Shares Float 547.8 K | Wall Street Target Price 36 |
Phio Pharmaceuticals Main Headline on 12th of December 2024
Phio Pharmaceuticals Announces Publication in Frontiers in I... by finance.yahoo.com
Journal is the official publication of the International Union of Immunological Societies Marlborough, Massachusetts-- - Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company developing therapeutics that use its INTASYL siRNA gene silencing technology designed to make the bodys immune cells more effective in killing cancer cells announced today its manuscript, Self-delivering RNAi Immunotherapeutic PH-762 Silences PD-1 to Genera
Phio Pharmaceuticals Valuation on December 12, 2024
It is possible to determine the worth of Phio Pharmaceuticals on a given historical date. On December 12, 2024 Phio was worth 2.79 at the beginning of the trading date compared to the closed value of 2.87. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Phio Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Phio Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Phio Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Phio Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.85 | 2.87 | 2.65 | 2.70 | 26,926 | |
12/12/2024 | 2.79 | 3.11 | 2.75 | 2.87 | 82,954 |
| 2.82 | 2.91 | 2.75 | 2.81 | 37,012 |
| Backtest Phio Pharmaceuticals | | | Phio Pharmaceuticals History | | | Phio Pharmaceuticals Valuation | Previous | Next |
Phio Pharmaceuticals Trading Date Momentum on December 12, 2024
| On December 13 2024 Phio Pharmaceuticals Corp was traded for 2.81 at the closing time. The top price for the day was 2.91 and the lowest listed price was 2.75 . The trading volume for the day was 37 K. The trading history from December 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.09% . The trading delta at closing time against the current closing price is 1.05% . |
Phio Pharmaceuticals Corp Fundamentals Correlations and Trends
By evaluating Phio Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Phio Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Phio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Phio Pharmaceuticals Stock history
Phio Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phio Pharmaceuticals Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phio Pharmaceuticals stock prices may prove useful in developing a viable investing in Phio Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 231.5 K | 243.1 K | |
| Net Loss | -15.3 M | -16 M |
Phio Pharmaceuticals Quarterly Net Working Capital |
|
Phio Pharmaceuticals Stock Technical Analysis
Phio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Phio Pharmaceuticals Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Phio Pharmaceuticals Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Phio Pharmaceuticals December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Phio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Phio Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Phio Pharmaceuticals stock market strength indicators, traders can identify Phio Pharmaceuticals Corp entry and exit signals to maximize returns
Phio Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phio Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.21) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phio Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (14.81) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.